Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
13.07 (1y: +12%)
Market Cap 266.21 M P/E(ttm) 15.20
Enterprise Value 220.75 M P/B 3.22
PETS- NAS (USA)
PetMed Express, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$13.07
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry		 vs
history
Cash to Debt No Debt
PETS's Cash to Debt is ranked higher than
97% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.55 vs. PETS: No Debt )
PETS' s 10-Year Cash to Debt Range
Min: 0.11   Max: No Debt
Current: No Debt
Interest Coverage No Debt
PETS's Interest Coverage is ranked higher than
65% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 41.95 vs. PETS: No Debt )
PETS' s 10-Year Interest Coverage Range
Min: 25   Max: No Debt
Current: No Debt
F-Score: 5
Z-Score: 23.8
M-Score: -2.24
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) 11.20
PETS's Operating margin (%) is ranked higher than
95% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.80 vs. PETS: 11.20 )
PETS' s 10-Year Operating margin (%) Range
Min: -26.4   Max: 17
Current: 11.2
-26.4
17
Net-margin (%) 7.1
PETS's Net-margin (%) is ranked higher than
94% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.50 vs. PETS: 7.1 )
PETS' s 10-Year Net-margin (%) Range
Min: -28.3   Max: 10.9
Current: 7.1
-28.3
10.9
Revenue Growth (%) 2.5
PETS's Revenue Growth (%) is ranked higher than
86% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.20 vs. PETS: 2.5 )
PETS' s 10-Year Revenue Growth (%) Range
Min: 2.5   Max: 40.8
Current: 2.5
2.5
40.8
EBITDA Growth (%) -7.4
PETS's EBITDA Growth (%) is ranked higher than
76% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.25 vs. PETS: -7.4 )
PETS' s 10-Year EBITDA Growth (%) Range
Min: -7.4   Max: 82.1
Current: -7.4
-7.4
82.1
EPS Growth (%) -7.8
PETS's EPS Growth (%) is ranked higher than
77% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.70 vs. PETS: -7.8 )
PETS' s 10-Year EPS Growth (%) Range
Min: -7.8   Max: 70.7
Current: -7.8
-7.8
70.7
» PETS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

PETS Guru Trades in Q2 2012

John Buckingham 90,754 sh (New)
Steven Cohen 17,863 sh (New)
Joel Greenblatt 102,679 sh (+162.75%)
Jim Simons 824,000 sh (+11.8%)
Chuck Royce 56,000 sh (unchged)
» More
Q3 2012

PETS Guru Trades in Q3 2012

Paul Tudor Jones 23,300 sh (New)
Jim Simons 1,340,609 sh (+62.7%)
John Buckingham 108,421 sh (+19.47%)
Joel Greenblatt 103,044 sh (+0.36%)
Chuck Royce 56,000 sh (unchged)
Steven Cohen Sold Out
» More
Q4 2012

PETS Guru Trades in Q4 2012

Joel Greenblatt 109,897 sh (+6.65%)
John Buckingham 113,014 sh (+4.24%)
Chuck Royce 56,000 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 1,196,315 sh (-10.76%)
» More
Q1 2013

PETS Guru Trades in Q1 2013

Steven Cohen 40,337 sh (New)
Paul Tudor Jones 17,700 sh (New)
Joel Greenblatt 153,161 sh (+39.37%)
Jim Simons 1,211,200 sh (+1.24%)
Chuck Royce 56,000 sh (unchged)
John Buckingham 112,926 sh (-0.08%)
» More
» Details

Insider Trades

Latest Guru Trades with PETS

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Add 39.37%0.03%$11.09 - $14.37 $ 13.072%153161
Joel Greenblatt 2012-06-30 Add 162.75%0.06%$11.15 - $13.46 $ 13.077%102679
Joel Greenblatt 2011-03-31 Add 326.98%0.2%$14.39 - $17.89 $ 13.07-14%53855
Joel Greenblatt 2010-12-31 New Buy0.07%$15.21 - $18.8 $ 13.07-24%12613
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about PetMed Express, Inc.

Horatio Gulash: Analyzing Advertising Expense
June 11, 2012
- Horatio Gulash: Analyzing Advertising Expense
Our last episode concluded with Horatio pondering various methods of growing his hot dog business. As you may recall, he still owes Pop a considerable amount of money which he must pay off within the next three years; thus far he has paid back approximately 40% of the debt. Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 15.10
PETS's P/E(ttm) is ranked higher than
80% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.24 vs. PETS: 15.10 )
PETS' s 10-Year P/E(ttm) Range
Min: 8.21   Max: 48.86
Current: 15.1
8.21
48.86
P/S 1.13
PETS's P/S is ranked lower than
83% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.30 vs. PETS: 1.13 )
PETS' s 10-Year P/S Range
Min: 0.28   Max: 3.51
Current: 1.13
0.28
3.51
PFCF 21.20
PETS's PFCF is ranked higher than
64% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.04 vs. PETS: 21.20 )
PETS' s 10-Year PFCF Range
Min: 7.86   Max: 6.6293E+17
Current: 21.2
7.86
6.6293E+17
EV-to-EBIT 7.8
PETS's EV-to-EBIT is ranked higher than
89% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.60 vs. PETS: 7.8 )
PETS' s 10-Year EV-to-EBIT Range
Min: 4.7   Max: 43.5
Current: 7.8
4.7
43.5
PEG 6.6
PETS's PEG is ranked lower than
75% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.20 vs. PETS: 6.6 )
PETS' s 10-Year PEG Range
Min: 0.29   Max: 17.85
Current: 6.6
0.29
17.85
Shiller P/E 13.2
PETS's Shiller P/E is ranked higher than
89% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.98 vs. PETS: 13.2 )
PETS' s 10-Year Shiller P/E Range
Min: 9.84   Max: 59.22
Current: 13.2
9.84
59.22

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 4.59
PETS's Dividend Yield is ranked higher than
97% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.82 vs. PETS: 4.59 )
PETS' s 10-Year Dividend Yield Range
Min: 0.51   Max: 5.85
Current: 4.59
0.51
5.85
Dividend Payout 0.7284
PETS's Dividend Payout is ranked higher than
63% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.52 vs. PETS: 0.7284 )
PETS' s 10-Year Dividend Payout Range
Min: 0.26   Max: 0.73
Current: 0.73
0.26
0.73
Dividend growth (3y) 18.9
PETS's Dividend growth (3y) is ranked lower than
78% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.70 vs. PETS: 18.9 )
PETS' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 18.9
Current: 18.9
0
18.9
Yield on cost (5-Year) 4.50
PETS's Yield on cost (5-Year) is ranked higher than
94% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.91 vs. PETS: 4.50 )
PETS' s 10-Year Yield on cost (5-Year) Range
Min: 0.51   Max: 5.85
Current: 4.5
0.51
5.85
Share Buyback Rate 3
PETS's Share Buyback Rate is ranked higher than
94% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.30 vs. PETS: 3 )
PETS' s 10-Year Share Buyback Rate Range
Min: 3.1   Max: -34.3
Current: 3

Valuation & Return

vs
industry		 vs
history
Price/DCF (Projected) 1
PETS's Price/DCF (Projected) is ranked higher than
87% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.95 vs. PETS: 1 )
PETS' s 10-Year Price/DCF (Projected) Range
Min: 0.8   Max: 6
Current: 1
0.8
6
Price/Median PS Value 0.7
PETS's Price/Median PS Value is ranked higher than
70% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.95 vs. PETS: 0.7 )
PETS' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 2
Current: 0.7
0.3
2
Earnings Yield (Greenblatt) 12.80
PETS's Earnings Yield (Greenblatt) is ranked higher than
92% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 9.30 vs. PETS: 12.80 )
PETS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.3   Max: 21.2
Current: 12.8
2.3
21.2
Forward Rate of Return (Yacktman) 3.34
PETS's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.33 vs. PETS: 3.34 )
PETS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.3   Max: 73.7
Current: 3.34
0.3
73.7

Business Description

PetMed Express, Inc. was incorporated in the state of Florida in January 1996. The company is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company offers consumers an alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. Its current product line contains approximately 1200 SKUS. These products include a majority of the well-known brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Interceptor, Program, Revolution, Deramaxx, and Rimadyl. In March 2010, the Company started offering for sale additional pet supplies on its website, which are drop shipped to its customers by third parties. These pet supplies include: food, beds, crates, stairs, strollers, and other popular pet supplies. It attracted approximately 19.1 million visitors to its website during fiscal 2012. Its website allows customers to easily browse and purchase all of its products online. Its website is designed to be fast, secure, and easy to use with order and shipping confirmations, and with online order tracking capabilities. It provides its customers with toll-free telephone access to its customer care representatives. Its call center generally operates from 8:00 AM to 11:00 PM, Monday through Thursday, 8:00 AM to 9:00 PM on Friday, 9:00 AM to 6:00 PM on Saturday, and 10:00 AM to 5:00 PM on Sunday, Eastern Time. The process of customers purchasing products from 1-800-PetMeds consists of a few simple steps. A customer first places a call to its toll-free telephone number or visits its website. The following information is needed to process prescription orders: pet information, prescription information, and the veterinarian's name and phone number. This information is entered into its computer system. Then its pharmacists and pharmacy technicians verify all prescriptions. The order process system checks for the verification for prescription medication orders and a valid payment method for all orders. An invoice is generated and printed in its fulfillment center, where items are picked, and then shipped via United States Postal Service, Federal Express, or UPS. Its customers enjoy the convenience of rapid home delivery, with approximately 80% of all orders being shipped within 24 hours of ordering. Its operations are subject to regulation by the State of Florida and are licensed as a community pharmacy by the Florida Board of Pharmacy.
Company Website
SEC Reports
Industry: Pharmaceutical Retailers
Compare:SHDMF, GNC, APNHY, JCOUF, PMC
Traded in other countries:PQM.Germany
» More Articles for PETS

Headlines

Articles On GuruFocus.com
PetMed Express - Debt-Free with Attractive Dividend Yield Nov 26 2012 
Horatio Gulash: Analyzing Advertising Expense Jun 11 2012 
12 Healthcare Dividend Stocks With Highest Short Float Ratio Jun 02 2012 
Why Investing in Pet Stocks Will Pay Off Apr 10 2012 
24 Stocks Growing Their Cash Dividends Feb 06 2012 
The Best Yielding Healthcare Dividend Stocks with Fastest Earnings Growth Feb 02 2012 
Value Idea Contest Winners Announcement Apr 12 2012 
PetMed Express (PETS) – Short-Term Pain and Undervalued Dec 14 2011 
The Stock Has Fleas but the Business Doesn't (PETS) Nov 30 2011 
Mr. Market Hammers PetMed ($PETS) Oct 05 2011 

More From Our Partners
Top 4 Stocks In The Drug Delivery Industry With The Lowest PEG Ratio May 22 2013 - BENZINGA

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial